Table 6.
Illness perceptions of patients with different chemotherapy regimens
| BIPQ scales | Netherlands | Japan | t test; p value |
|---|---|---|---|
| M (SD) | M (SD) | ||
| Consequences | |||
| TAC | 7.6 (1.7) | –a | – |
| AC | 6.9 (2.3) | 5.4 (2.8) | 0.003 |
| FEC | 6.4 (2.1) | 6.5 (2.6) | n.s. |
| TC | –a | 6.1 (2.9) | – |
| n.s.b | n.s.b | ||
| Timeline | |||
| TAC | 5.5 (3.0) | –a | – |
| AC | 5.8 (2.7) | 6.3 (2.2) | n.s. |
| FEC | 5.4 (3.4) | 6.7 (2.4) | n.s. |
| TC | –a | 5.8 (2.4) | – |
| n.s.b | n.s.b | ||
| Personal Control | |||
| TAC | 5.0 (2.9) | –a | – |
| AC | 4.5 (2.7) | 6.3 (2.1) | 0.001 |
| FEC | 4.8 (3.1) | 5.7 (2.0) | n.s. |
| TC | –a | 5.7 (2.1) | – |
| n.s.b | n.s.b | ||
| Treatment Control | |||
| TAC | 8.8 (1.3) | –a | – |
| AC | 8.4 (1.3) | 6.7 (2.1) | <0.001 |
| FEC | 9.1 (1.1) | 7.4 (1.8) | <0.001 |
| TC | –a | 6.7 (1.6) | – |
| n.s.b | n.s.b | ||
| Identity | |||
| TAC | 4.0 (2.3) | –a | – |
| AC | 3.2 (2.1) | 2.7 (2.1) | n.s. |
| FEC | 3.8 (2.2) | 3.0 (2.5) | n.s. |
| TC | –a | 2.6 (2.2) | – |
| n.s.b | n.s.b | ||
| Concerns | |||
| TAC | 5.6 (2.5) | –a | – |
| AC | 6.7 (2.4) | 7.3 (2.4) | n.s. |
| FEC | 4.9 (3.1) | 7.2 (2.6) | 0.008 |
| TC | –a | 6.5 (2.7) | – |
| n.s.b | n.s.b | ||
| Coherence | |||
| TAC | 7.0 (2.4) | –a | – |
| AC | 6.9 (2.4) | 6.5 (2.0) | n.s. |
| FEC | 5.7 (2.7) | 6.6 (1.6) | n.s. |
| TC | –a | 6.9 (1.7) | – |
| n.s.b | n.s.b | ||
| Emotional Representations | |||
| TAC | 4.9 (2.3) | –a | – |
| AC | 5.7 (2.4) | 4.1 (2.7) | 0.003 |
| FEC | 4.6 (3.1) | 4.6 (2.6) | n.s. |
| TC | –a | 4.7 (2.4) | – |
| n.s.b | n.s.b | ||
aOnly mean scores are displayed if number of observations per group >15
bManova multivariate F-scores for illness perception domains within each country (between group: chemotherapy) are not significant: p = 0.12 the Netherlands and p = 0.33 in Japan